RU97117163A - INTRODUCED BY INJECTION ONCE TIME IN MONTH, THE COMPOSITION AS A CONTRACEPTIVE OF LONG-TERM ACTION AND IN HORM-REPLACING THERAPY FOR PERI- AND PRE-PAINHOUSAL WOMEN - Google Patents
INTRODUCED BY INJECTION ONCE TIME IN MONTH, THE COMPOSITION AS A CONTRACEPTIVE OF LONG-TERM ACTION AND IN HORM-REPLACING THERAPY FOR PERI- AND PRE-PAINHOUSAL WOMENInfo
- Publication number
- RU97117163A RU97117163A RU97117163/14A RU97117163A RU97117163A RU 97117163 A RU97117163 A RU 97117163A RU 97117163/14 A RU97117163/14 A RU 97117163/14A RU 97117163 A RU97117163 A RU 97117163A RU 97117163 A RU97117163 A RU 97117163A
- Authority
- RU
- Russia
- Prior art keywords
- component
- peri
- women
- estradiol
- painhousal
- Prior art date
Links
- 230000002254 contraceptive Effects 0.000 title 1
- 239000003433 contraceptive agent Substances 0.000 title 1
- 238000002347 injection Methods 0.000 title 1
- 239000007924 injection Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 239000000262 estrogen Substances 0.000 claims 3
- RSEPBGGWRJCQGY-RBRWEJTLSA-N Estradiol valerate Chemical compound C1CC2=CC(O)=CC=C2[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)CCCC)[C@@]1(C)CC2 RSEPBGGWRJCQGY-RBRWEJTLSA-N 0.000 claims 2
- APTGJECXMIKIET-WOSSHHRXSA-N Norethindrone enanthate Chemical compound C1CC2=CC(=O)CC[C@@H]2[C@@H]2[C@@H]1[C@@H]1CC[C@](C#C)(OC(=O)CCCCCC)[C@@]1(C)CC2 APTGJECXMIKIET-WOSSHHRXSA-N 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 229960002985 medroxyprogesterone acetate Drugs 0.000 claims 2
- PSGAAPLEWMOORI-PEINSRQWSA-N medroxyprogesterone acetate Chemical compound C([C@@]12C)CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2CC[C@]2(C)[C@@](OC(C)=O)(C(C)=O)CC[C@H]21 PSGAAPLEWMOORI-PEINSRQWSA-N 0.000 claims 2
- 229960002082 norethindrone enanthate Drugs 0.000 claims 2
- 230000001072 progestational Effects 0.000 claims 2
- 239000000583 progesterone congener Substances 0.000 claims 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 claims 1
- UYIFTLBWAOGQBI-BZDYCCQFSA-N Benzhormovarine Chemical compound C([C@@H]1[C@@H](C2=CC=3)CC[C@]4([C@H]1CC[C@@H]4O)C)CC2=CC=3OC(=O)C1=CC=CC=C1 UYIFTLBWAOGQBI-BZDYCCQFSA-N 0.000 claims 1
- 229960000978 Cyproterone Acetate Drugs 0.000 claims 1
- UWFYSQMTEOIJJG-FDTZYFLXSA-N Cyproterone acetate Chemical compound C1=C(Cl)C2=CC(=O)[C@@H]3C[C@@H]3[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 UWFYSQMTEOIJJG-FDTZYFLXSA-N 0.000 claims 1
- 229960005309 Estradiol Drugs 0.000 claims 1
- UOACKFBJUYNSLK-XRKIENNPSA-N Estradiol 17β-cyclopentylpropionate Chemical group O([C@H]1CC[C@H]2[C@H]3[C@@H](C4=CC=C(O)C=C4CC3)CC[C@@]21C)C(=O)CCC1CCCC1 UOACKFBJUYNSLK-XRKIENNPSA-N 0.000 claims 1
- IMONTRJLAWHYGT-ZCPXKWAGSA-N Norethindrone Acetate Chemical compound C1CC2=CC(=O)CC[C@@H]2[C@@H]2[C@@H]1[C@@H]1CC[C@](C#C)(OC(=O)C)[C@@]1(C)CC2 IMONTRJLAWHYGT-ZCPXKWAGSA-N 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229960001359 estradiol 3-benzoate Drugs 0.000 claims 1
- 229960004766 estradiol valerate Drugs 0.000 claims 1
- 150000002159 estradiols Chemical class 0.000 claims 1
- 230000001076 estrogenic Effects 0.000 claims 1
- 238000002657 hormone replacement therapy Methods 0.000 claims 1
- 239000007972 injectable composition Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 229960001652 norethindrone acetate Drugs 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
Claims (5)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19510861.2 | 1995-03-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
RU97117163A true RU97117163A (en) | 1999-08-10 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1033948C (en) | Process for preparing dihydrosprironenon of antiandrogen | |
RU2091069C1 (en) | Agent for hormonal contraception that inhibits ovulation | |
DE69118494T2 (en) | Contraception procedure and scheme | |
KR920011517A (en) | Low Estrogen Oral Contraceptives | |
RU96119957A (en) | PHARMACEUTICAL COMBINED DRUG FOR HORMONAL CONTRACEPTION | |
RU96119803A (en) | COMBINED DRUG FOR CONTRACEPTION BASED ON NATURAL ESTROGENS | |
RU96100843A (en) | COMPOSITION BASED ON SUGAR FOR APPLICATION ON A TABLET, PRESSED TABLET | |
RU96118462A (en) | Transdermal Therapy Systems Containing Sex Steroids | |
KR960028919A (en) | Regulated release of steroids from saccharide coatings | |
RU96115196A (en) | COMPOSITION FOR CONTRACEPTION | |
KR970069031A (en) | Pharmaceutical tablets with controlled release of steroids from sugar coating | |
DK365887D0 (en) | COMBINATION DOSAGE FOR HORMONE TREATMENT OF WOMEN IN PRAE-MENOPAUSUS | |
RU2001129160A (en) | Intermittent hormone replacement therapy with low doses of estrogen | |
KR970704450A (en) | Use of a progesterone antagonist and gestagen to treat endometrial hyperplasia or uterine leiomyoma (Use of a Progesterone Antagonist and a Gestagen for Endometriosis or Leiomyomate Uteri) | |
Sakiz et al. | A new approach to estrogen-free contraception based on progesterone receptor blockage by mid-cycle administration of ethyl norgestrienone (R 2323) | |
RU97117163A (en) | INTRODUCED BY INJECTION ONCE TIME IN MONTH, THE COMPOSITION AS A CONTRACEPTIVE OF LONG-TERM ACTION AND IN HORM-REPLACING THERAPY FOR PERI- AND PRE-PAINHOUSAL WOMEN | |
GB1462893A (en) | Method for fertile breeding control in female bovine | |
EP0889727B1 (en) | Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy | |
RU1789216C (en) | Composition showing contraceptive effect | |
NZ304027A (en) | Once a month injectable contraceptive comprising an estrogenic and gestagenic component for contraception and simultaneous hormone replacement therapy | |
Hall | Once-a-month injectable contraceptives | |
ES363068A1 (en) | 11beta-CHLORO-19-NOR-STEROIDS | |
RU2000118225A (en) | Subcutaneous Introduction of Medroxyprogesterone Acetate for the Treatment of Menopause and Endometriosis | |
RU97103327A (en) | APPLICATION OF A COMBINED PRODUCT CONTAINING A COMPETING PROGESTERON AND HESTAGEN ANTAGONIST TO PRODUCE A MEDICINE FOR THE TREATMENT OF ENDOMETRIOSIS OR LEIOMYOMATATER | |
GB1313659A (en) | 9alpha-unsubstituted-11beta-chloro-19-norpregnane compounds |